1273315-56-2

Upstream product

• 1529-41-5 3-chloro-benzeneacetonitrile 
• 6487-96-3 2-(3-chlorophenyl)ethaneimidamide hydrochloric acid salt 
• 87-13-8 diethyl 2-ethoxymethylenemalonate 

Downstream Products

• 1273315-60-8 ethyl 2-(3-chlorobenzyl)-4-(methylamino)pyrimidine-5-carboxylate 
• 1273315-62-0 2-(3-chlorobenzyl)-4-(methylamino)pyrimidine-5-carboxylate 
• 1273315-64-2 2-(3-chlorobenzyl)-9-methyl-7,9-dihydro-8H-purine-8-one 

Relevant academic research and scientific papers

8-OXODIHYDROPURINE DERIVATIVE

The present invention provides a compound represented by the formula (1) or a pharmaceutically acceptable salt thereof (wherein W represents a hydrogen atom, a halogen atom, or the others; A represents an alkyl group optionally substituted by aryl group or the others, an aryl group, or the others; and one of X and Y represents a di-substituted alkylaminocarbonyl group, or the others, and the other represents a hydrogen atom, an alkyl group, an alkylcarbonyl group, or the others); a medicament or a pharmaceutical composition for treatment or prophylaxis of FAAH-related diseases such as depression, anxiety disorder or pains, comprising the compound or the like as an active ingredient; a use of the compound or the like; and a method for treatment or prophylaxis using the compound or the like.